Antônio C. Buzaid

14.1k total citations · 2 hit papers
139 papers, 10.4k citations indexed

About

Antônio C. Buzaid is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Antônio C. Buzaid has authored 139 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Oncology, 52 papers in Molecular Biology and 24 papers in Immunology. Recurrent topics in Antônio C. Buzaid's work include Cutaneous Melanoma Detection and Management (38 papers), Melanoma and MAPK Pathways (27 papers) and Immunotherapy and Immune Responses (20 papers). Antônio C. Buzaid is often cited by papers focused on Cutaneous Melanoma Detection and Management (38 papers), Melanoma and MAPK Pathways (27 papers) and Immunotherapy and Immune Responses (20 papers). Antônio C. Buzaid collaborates with scholars based in United States, Brazil and Australia. Antônio C. Buzaid's co-authors include Merrick I. Ross, Michael B. Atkins, Charles M. Balch, John M. Kirkwood, Jeffrey E. Gershenwald, Kelly M. McMasters, John F. Thompson, Daniel G. Coit, Donald L. Morton and Arthur J. Sober and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Antônio C. Buzaid

135 papers receiving 10.1k citations

Hit Papers

Final Version of 2009 AJCC Melanoma Staging and Classific... 2001 2026 2009 2017 2009 2001 1000 2.0k 3.0k

Peers

Antônio C. Buzaid
John A. Thompson United States
Mark B. Faries United States
Lynn M. Schuchter United States
Alan Spatz France
Svetomir N. Markovic United States
Mark R. Middleton United Kingdom
Iman Osman United States
John A. Thompson United States
Antônio C. Buzaid
Citations per year, relative to Antônio C. Buzaid Antônio C. Buzaid (= 1×) peers John A. Thompson

Countries citing papers authored by Antônio C. Buzaid

Since Specialization
Citations

This map shows the geographic impact of Antônio C. Buzaid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antônio C. Buzaid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antônio C. Buzaid more than expected).

Fields of papers citing papers by Antônio C. Buzaid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antônio C. Buzaid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antônio C. Buzaid. The network helps show where Antônio C. Buzaid may publish in the future.

Co-authorship network of co-authors of Antônio C. Buzaid

This figure shows the co-authorship network connecting the top 25 collaborators of Antônio C. Buzaid. A scholar is included among the top collaborators of Antônio C. Buzaid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antônio C. Buzaid. Antônio C. Buzaid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taranto, Patrícia, Fernando Cotait Maluf, Luciano de Melo Pompei, et al.. (2024). Safety and efficacy of topical testosterone in breast cancer patients receiving ovarian suppression and aromatase inhibitor therapy. Breast Cancer Research. 26(1). 133–133. 3 indexed citations
2.
Gagliato, Débora De Melo, et al.. (2023). Efficacy of ovarian function suppression of 3-monthly versus monthly GnRH agonist as endocrine therapy for premenopausal breast cancer patients.. Journal of Clinical Oncology. 41(16_suppl). 527–527. 1 indexed citations
3.
Buzaid, Antônio C., et al.. (2023). Real-world outcomes of long-term efficacy of T-DM1 after discontinuation due to limiting toxicity in patients with HER2-positive metastatic breast cancer.. Journal of Clinical Oncology. 41(16_suppl). e13034–e13034. 1 indexed citations
4.
Gagliato, Débora De Melo, Antônio C. Buzaid, José Manuel Pérez-García, & Javier Cortés. (2020). Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges. BioDrugs. 34(5). 611–623. 43 indexed citations
5.
Filho, Renato Santos de Oliveira, Francisco Macedo Paschoal, Gisele Gargantini Rezze, et al.. (2019). Literature review of Notch melanoma receptors. SHILAP Revista de lepidopterología. 2(1). 2 indexed citations
6.
Bines, José, Helena Earl, Antônio C. Buzaid, & Everardo D. Saad. (2014). Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?. Annals of Oncology. 25(6). 1079–1085. 55 indexed citations
7.
Buzaid, Antônio C., et al.. (2013). Low-Dose Bevacizumab Is Effective in Radiation-Induced Necrosis. Case Reports in Oncology. 6(3). 598–601. 15 indexed citations
8.
Buzaid, Antônio C., Sérgio D. Simon, Luis Fein, et al.. (2010). Cetuximab Plus Irinotecan in Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: The LABEL Study. Clinical Colorectal Cancer. 9(5). 282–289. 10 indexed citations
9.
Balch, Charles M., Jeffrey E. Gershenwald, Seng-Jaw Soong, et al.. (2009). Final Version of 2009 AJCC Melanoma Staging and Classification. Journal of Clinical Oncology. 27(36). 6199–6206. 3342 indexed citations breakdown →
10.
Mohr, Peter, Alexander M.M. Eggermont, Axel Hauschild, & Antônio C. Buzaid. (2009). Staging of cutaneous melanoma. Annals of Oncology. 20. vi14–vi21. 67 indexed citations
12.
Balch, Charles M., Antônio C. Buzaid, Seng‐Jaw Soong, et al.. (2003). New TNM melanoma staging system: Linking biology and natural history to clinical outcomes. Seminars in Surgical Oncology. 21(1). 43–52. 93 indexed citations
13.
Eton, Omar, Michael G. Rosenblum, Sewa S. Legha, et al.. (2002). Phase I trial of subcutaneous recombinant human interleukin‐2 in patients with metastatic melanoma. Cancer. 95(1). 127–134. 37 indexed citations
14.
Eton, Omar, Merrick I. Ross, K Itoh, et al.. (1998). Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.. PubMed. 4(3). 619–27. 23 indexed citations
15.
Legha, S S, Sigrid Ring, Omar Eton, et al.. (1998). Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.. Journal of Clinical Oncology. 16(5). 1752–1759. 221 indexed citations
16.
Sporn, Jonathan, et al.. (1997). Treatment of Advanced Pancreatic Adenocarcinoma with 5-FU, Leucovorin, Interferon-α-2b, and Cisplatin. American Journal of Clinical Oncology. 20(1). 81–83. 13 indexed citations
17.
Anderson, Clay M., Antônio C. Buzaid, & Elizabeth A. Grimm. (1996). Interaction of Chemotherapy and Biological Response Modifiers in the Treatment of Melanoma. Cancer treatment and research. 87. 357–380. 2 indexed citations
18.
Anderlini, Paolo, Antônio C. Buzaid, & Sewa S. Legha. (1995). Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanoma. Cancer. 76(4). 678–679. 22 indexed citations
19.
Murren, John R., Antônio C. Buzaid, & William N. Hait. (1991). Critical Analysis of Neoadjuvant Therapy for State Illa Non-Small Cell Lung Cancer. American Review of Respiratory Disease. 143(4_pt_1). 889–894. 23 indexed citations
20.
Buzaid, Antônio C., et al.. (1987). Salvage therapy of advanced hodgkin's disease. The American Journal of Medicine. 83(3). 523–532. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026